Consistently, assessment of tumor perfusion vessels using lectin‐labeled vascular endothelium (green) and CD31‐labeled total blood vessels (red) showed an obvious increase in the proportion of perfusion vessels within tumor treated with PFD@Gel, which could be attributed to the reduced compression of vessels by the softened ECM (Figure S15, Supporting Information). This evidence concerns the gene PECAM1 and neoplasm.